Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 11, Pages e1238540
Publisher
Informa UK Limited
Online
2016-09-28
DOI
10.1080/2162402x.2016.1238540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An optimized antibody-single-chain TRAIL fusion protein for cancer therapy
- (2016) Martin Siegemund et al. mAbs
- Principles of antibody-mediated TNF receptor activation
- (2015) H Wajant CELL DEATH AND DIFFERENTIATION
- Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells
- (2015) Isabell Lang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody fusions with immunomodulatory proteins for cancer therapy
- (2015) Dafne Müller PHARMACOLOGY & THERAPEUTICS
- Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS
- (2015) Miguel F. Sanmamed et al. SEMINARS IN ONCOLOGY
- SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines
- (2014) Rajesh K Sharma et al. Expert Review of Vaccines
- Tumor targeting properties of antibody fusion proteins based on different members of the murine tumor necrosis superfamily
- (2014) Teresa Hemmerle et al. JOURNAL OF BIOTECHNOLOGY
- Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity
- (2014) A. Krippner-Heidenreich et al. JOURNAL OF IMMUNOLOGY
- Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly
- (2014) Weifeng Liu et al. STRUCTURE
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Evaluating combinations of costimulatory antibody–ligand fusion proteins for targeted cancer immunotherapy
- (2013) Nora Hornig et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells
- (2013) I. Melero et al. CLINICAL CANCER RESEARCH
- Tetravalent Antibody-scTRAIL Fusion Proteins with Improved Properties
- (2013) O. Seifert et al. MOLECULAR CANCER THERAPEUTICS
- Clinical targeting of the TNF and TNFR superfamilies
- (2013) Michael Croft et al. NATURE REVIEWS DRUG DISCOVERY
- Antibody–cytokine fusion proteins
- (2012) Roland E. Kontermann ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas
- (2012) K. A. Murphy et al. CLINICAL CANCER RESEARCH
- Combination of a Bispecific Antibody and Costimulatory Antibody-Ligand Fusion Proteins for Targeted Cancer Immunotherapy
- (2012) Nora Hornig et al. JOURNAL OF IMMUNOTHERAPY
- Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
- (2012) M Siegemund et al. Cell Death & Disease
- Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
- (2010) Juan Dubrot et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen
- (2010) Claudia Bluemel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
- (2010) Paolo A. Ascierto et al. SEMINARS IN ONCOLOGY
- Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins
- (2010) B Schneider et al. Cell Death & Disease
- Sequence, structure, function, immunity: structural genomics of costimulation
- (2009) Kausik Chattopadhyay et al. IMMUNOLOGICAL REVIEWS
- The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily
- (2009) Eun-Young Won et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
- (2009) A. Wyzgol et al. JOURNAL OF IMMUNOLOGY
- Fc-mOX40L Fusion Protein Produces Complete Remission and Enhanced Survival in 2 Murine Tumor Models
- (2009) Rebecca E. Sadun et al. JOURNAL OF IMMUNOTHERAPY
- A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
- (2009) Rich-Henry Schabowsky et al. VACCINE
- A Novel Antibody–4-1BBL Fusion Protein for Targeted Costimulation in Cancer Immunotherapy
- (2008) Dafne Müller et al. JOURNAL OF IMMUNOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search